Sign Out
Gastrointestinal: Gastrointestinal bleeding has been rarely reported; use in patients with active peptic or duodenal ulcers is contraindicated in some product labels.
Respiratory: Use with caution in patients with chronic bronchial asthma or respiratory failure. Paradoxical respiratory adverse effects including increased bronchial secretions leading to hospitalization have been reported in infants and children from 2.5 to 34 months; effects may be related to decreased spontaneous drainage in this population.
Effects on ability to drive and use machines: Carbocisteine has no or negligible influence on the ability to drive and use machines.
Use in Children: Use is contraindicated in infants and children <2 years. Capsules dosage form is not recommended for use in children <12 years.
Continue with Google